Rusak et al. showed that CLL patients with advanced high-risk disease (stages III and IV) had a higher number of CD4+/PD1+ circulating T cells in peripheral blood compared with low-risk and intermediate-risk subjects (22). The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.